531689 — Mahavir Advanced Remedies Income Statement
0.000.00%
Consumer DefensivesMicro Cap
Annual income statement for Mahavir Advanced Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2010 March 31st | 2011 March 31st | 2012 March 31st | 2013 March 31st | 2014 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.92 | 2.4 | 2.08 | 1.45 | 3.2 |
| Cost of Revenue | |||||
| Gross Profit | 0.554 | 0.756 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2.55 | 2.88 | 5.25 | 2.98 | 1.82 |
| Operating Profit | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
| Net Income Before Taxes | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.126 | -0.094 | -0.633 | -0.135 | 0.121 |
| Dividends per Share |